Company registration number 08639939 (England and Wales)
PLAS-TECH INJECTION MOULDING LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
PLAS-TECH INJECTION MOULDING LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 9
PLAS-TECH INJECTION MOULDING LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
37,206
86,091
Current assets
Stocks
26,791
31,551
Debtors
5
102,662
80,571
Cash at bank and in hand
36,973
22,845
166,426
134,967
Creditors: amounts falling due within one year
6
(179,287)
(159,860)
Net current liabilities
(12,861)
(24,893)
Total assets less current liabilities
24,345
61,198
Creditors: amounts falling due after more than one year
7
(11,484)
(17,901)
Provisions for liabilities
(9,300)
(21,500)
Net assets
3,561
21,797
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
3,560
21,796
Total equity
3,561
21,797

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 6 August 2026 and are signed on its behalf by:
Mr M R Wilson
Director
Company registration number 08639939 (England and Wales)
PLAS-TECH INJECTION MOULDING LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Plas-Tech Injection Moulding Limited is a private company limited by shares incorporated in England and Wales. The registered office is Kingfisher Court, Plaxton Bridge Road, Woodmansey, Beverley, HU17 0RT.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The immediate parent company is Poly Plastics Limited and the ultimate parent company is IGA Holdings Limited. IGA Holdings Limited is the smallest and largest group into which these financial statements are consolidated, and these group accounts can be obtained from its registered office of IGA Holdings Limited, c/o Azets, Monks Cross Drive, Huntington, York, YO32 9GZ.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

PLAS-TECH INJECTION MOULDING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% straight line
Computers
33% straight line
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

PLAS-TECH INJECTION MOULDING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

PLAS-TECH INJECTION MOULDING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

PLAS-TECH INJECTION MOULDING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

1.15
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
11
8
PLAS-TECH INJECTION MOULDING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 January 2025 and 31 December 2025
230,000
Amortisation and impairment
At 1 January 2025 and 31 December 2025
230,000
Carrying amount
At 31 December 2025
-
0
At 31 December 2024
-
0
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2025 and 31 December 2025
488,746
Depreciation and impairment
At 1 January 2025
402,655
Depreciation charged in the year
48,885
At 31 December 2025
451,540
Carrying amount
At 31 December 2025
37,206
At 31 December 2024
86,091
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
55,486
33,609
Amounts owed by group undertakings
42,560
46,578
Other debtors
4,616
384
102,662
80,571

Amounts owed by group undertakings are unsecured, interest free and repayable on demand.

PLAS-TECH INJECTION MOULDING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
21,417
2,459
Amounts owed to group undertakings
69,847
78,480
Taxation and social security
40,145
43,245
Other creditors
47,878
35,676
179,287
159,860

Amounts owed to group undertakings are unsecured, interest free and repayable on demand.

Included within other creditors are hire purchase obligations totalling £6,489 (2024 - £6,091). Obligations are secured against the asset to which they relate.

Also included within other creditors are unsecured loans from the directors totalling £1,203 (2024 - £1,203).

7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
11,484
17,901

Included within other creditors are hire purchase obligations totalling £11,484 (2024 - £17,901). Obligations are secured against the asset to which they relate.

8
Operating lease commitments
As lessee

Operating lease payments represent rentals payable by the company for certain of its properties and assets.

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2025
2024
£
£
Total commitments
262,467
271,125
9
Parent company

The immediate parent company is Poly Plastics Limited and the ultimate parent company is IGA Holdings Limited. IGA Holdings Limited is the smallest and largest group into which these financial statements are consolidated, and these group accounts can be obtained from its registered office of IGA Holdings Limited, c/o Azets, Monks Cross Drive, Huntington, York, YO32 9GZ.

PLAS-TECH INJECTION MOULDING LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
10
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion, except for the possible effects of the matter described in the basis for opinion paragraph, the financial statements:

- give a true and fair view of the state of the company's affairs as at 31st December 2025 and of its profit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Senior Statutory Auditor:
Statutory Auditor:
Smailes Goldie Chartered Accountants
Date of audit report:
6 August 2026
2025-12-31 2025-01-01 false false false 06 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr J A Jarvis Mr J R Rial Ms V J Rial Mr M R Wilson Mrs Z Whitney Mr R Lakshmipathi Mr T Ketley Williams Cowell FCA 08639939 2025-01-01 2025-12-31 08639939 2025-12-31 08639939 2024-12-31 08639939 core:OtherPropertyPlantEquipment 2025-12-31 08639939 core:OtherPropertyPlantEquipment 2024-12-31 08639939 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 08639939 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 08639939 core:WithinOneYear 2025-12-31 08639939 core:WithinOneYear 2024-12-31 08639939 core:AfterOneYear 2025-12-31 08639939 core:AfterOneYear 2024-12-31 08639939 core:CurrentFinancialInstruments 2025-12-31 08639939 core:CurrentFinancialInstruments 2024-12-31 08639939 core:ShareCapital 2025-12-31 08639939 core:ShareCapital 2024-12-31 08639939 core:RetainedEarningsAccumulatedLosses 2025-12-31 08639939 core:RetainedEarningsAccumulatedLosses 2024-12-31 08639939 bus:Director4 2025-01-01 2025-12-31 08639939 core:Goodwill 2025-01-01 2025-12-31 08639939 core:PlantMachinery 2025-01-01 2025-12-31 08639939 core:ComputerEquipment 2025-01-01 2025-12-31 08639939 core:MotorVehicles 2025-01-01 2025-12-31 08639939 2024-01-01 2024-12-31 08639939 core:NetGoodwill 2024-12-31 08639939 core:NetGoodwill 2025-12-31 08639939 core:NetGoodwill 2024-12-31 08639939 core:OtherPropertyPlantEquipment 2024-12-31 08639939 core:OtherPropertyPlantEquipment 2025-01-01 2025-12-31 08639939 core:Non-currentFinancialInstruments 2025-12-31 08639939 core:Non-currentFinancialInstruments 2024-12-31 08639939 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 08639939 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 08639939 bus:FRS102 2025-01-01 2025-12-31 08639939 bus:Audited 2025-01-01 2025-12-31 08639939 bus:Director1 2025-01-01 2025-12-31 08639939 bus:Director2 2025-01-01 2025-12-31 08639939 bus:Director3 2025-01-01 2025-12-31 08639939 bus:Director5 2025-01-01 2025-12-31 08639939 bus:Director6 2025-01-01 2025-12-31 08639939 bus:Director7 2025-01-01 2025-12-31 08639939 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP